$125 | Single User
$250 | Site License
$375 | Global License

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 05-12-2018]

Published by Global Data: 05 Dec 2018 | 227945 | In Stock

Introduction

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroSearch AS (NeuroSearch) focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system (CNS) through license agreements with other life science companies. The company divested all rights of Huntexil for the treatment of patients with Huntington's disease to Teva Pharmaceuticals. It also sold all the preclinical and clinical assets, and further development of NS2330 (tesofensine) and NS2359 as well as of any potential drugs based on NS2330 or NS2359 to Saniona A/S and Saniona AB (Saniona). NeuroSearch is entitled to receive a one-time cash payment from Saniona and milestone payments from Teva. NeuroSearch is headquartered in Hallerup, Denmark.

NeuroSearch AS Key Recent Developments

Aug 30,2018: NeuroSearch – H1 report 2018

Dec 05,2017: Update on NeuroSearch’s business status and future

Aug 31,2017: NeuroSearch – H1 report 2017

Feb 24,2017: NeuroSearch releasing Annual Report 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 05-12-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Section 1 - About the Company 5

    NeuroSearch AS - Key Facts 5

    NeuroSearch AS - Key Employees 6

    NeuroSearch AS - Key Employee Biographies 7

    NeuroSearch AS - Major Products and Services 8

    NeuroSearch AS - History 9

    NeuroSearch AS - Company Statement 13

    NeuroSearch AS - Locations And Subsidiaries 14

    Head Office 14

    Other Locations & Subsidiaries 14

    Section 2 – Company Analysis 15

    Company Overview 15

    NeuroSearch AS - Business Description 16

    NeuroSearch AS - SWOT Analysis 17

    SWOT Analysis - Overview 17

    NeuroSearch AS - Strengths 17

    NeuroSearch AS - Weaknesses 18

    NeuroSearch AS - Opportunities 19

    NeuroSearch AS - Threats 20

    NeuroSearch AS - Key Competitors 21

    Section 3 – Company Financial Ratios 22

    Financial Ratios - Capital Market Ratios 22

    Financial Ratios - Annual Ratios 23

    Performance Chart 25

    Financial Performance 25

    Financial Ratios - Interim Ratios 26

    Financial Ratios - Ratio Charts 27

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 28

    NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

    NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

    NeuroSearch AS, Recent Deals Summary 30

    Section 5 – Company’s Recent Developments 31

    Aug 30, 2018: NeuroSearch – H1 report 2018 31

    Dec 05, 2017: Update on NeuroSearch’s business status and future 33

    Aug 31, 2017: NeuroSearch – H1 report 2017 34

    Feb 24, 2017: NeuroSearch releasing Annual Report 2016 36

    Section 6 – Appendix 38

    Methodology 38

    Ratio Definitions 38

    About GlobalData 42

    Contact Us 42

    Disclaimer 42

List Of Tables
in NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 05-12-2018]

List of Tables

NeuroSearch AS, Key Facts 5

NeuroSearch AS, Key Employees 6

NeuroSearch AS, Key Employee Biographies 7

NeuroSearch AS, Major Products and Services 8

NeuroSearch AS, History 9

NeuroSearch AS, Subsidiaries 14

NeuroSearch AS, Key Competitors 21

NeuroSearch AS, Ratios based on current share price 22

NeuroSearch AS, Annual Ratios 23

NeuroSearch AS, Annual Ratios (Cont...1) 24

NeuroSearch AS, Interim Ratios 26

NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

NeuroSearch AS, Recent Deals Summary 30

Currency Codes 38

Capital Market Ratios 38

Equity Ratios 39

Profitability Ratios 39

Cost Ratios 40

Liquidity Ratios 40

Leverage Ratios 41

Efficiency Ratios 41

List Of Figures, Charts and Diagrams
in NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 05-12-2018]

List of Figures

NeuroSearch AS, Performance Chart (2013 - 2017) 25

NeuroSearch AS, Ratio Charts 27

NeuroSearch AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

NeuroSearch AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

Additional Details

Publisher

Global Data

Publisher Information

Reference

227945 | GDPH62301FSA

Number of Pages

42

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) focuses on the development of novel pharmaceutical agents for t...
28 Nov 2017 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review
NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strate...
17 Oct 2017 by Global Data USD $125 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) develops novel pharmaceutical agents for the treatment of vario...
27 Jul 2017 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) develops novel pharmaceutical agents for the treatment of vario...
17 May 2017 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) develops novel pharmaceutical agents for the treatment of vario...
20 Mar 2017 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) develops novel pharmaceutical agents for the treatment of vario...
25 Nov 2016 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutic...
24 Aug 2016 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutic...
15 Apr 2016 by Global Data USD $250 More Info
NeuroSearch A/S – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutic...
08 Mar 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 05-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data